Search research articles
Contact Us
Filters
Showing results (41-50 of 162) with videos related to
Page
of 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 26, 2005
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children
Stephen I Pelton, Kenneth Stanley, Ram Yogev, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 7, 2019
Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo
Jennifer L Welch, Hussein Kaddour, Lee Winchester, et al.
AIDS Research and Human Retroviruses
|
October 26, 2010
Implications of HIV PrEP trials results
Fulvia Veronese, Peter Anton, Courtney V Fletcher, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy
Richard C Brundage, Florence H Yong, Terence Fenton, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 4, 2026
Quantification of nirmatrelvir concentrations in rat plasma, cerebrospinal fluid, and peripheral blood mononuclear cell extracts using LC-MS/MS
Timothy M Mykris, Lee Winchester, Johid R Malik, et al.
Journal of Clinical Pharmacology
|
January 15, 2011
Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men
Obi C Umeh, Judith S Currier, Jeong-Gun Park, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2014
Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women
Caroline Mitchell, Emily Roemer, Evangelyn Nkwopara, et al.
The Journal of Infectious Diseases
|
March 20, 2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359
Courtney V Fletcher, Hongyu Jiang, Richard C Brundage, et al.
Scientific Reports
|
July 30, 2020
Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
Shetty Ravi Dyavar, Timothy M Mykris, Lee C Winchester, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 10, 2008
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients
Jennifer J Kiser, Christina L Aquilante, Peter L Anderson, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 162) with videos related to
Sort By:
Page
of 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 26, 2005
Switch from ritonavir to indinavir in combination therapy for HIV-1-infected children
Stephen I Pelton, Kenneth Stanley, Ram Yogev, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
December 7, 2019
Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo
Jennifer L Welch, Hussein Kaddour, Lee Winchester, et al.
AIDS Research and Human Retroviruses
|
October 26, 2010
Implications of HIV PrEP trials results
Fulvia Veronese, Peter Anton, Courtney V Fletcher, et al.
Antimicrobial Agents and Chemotherapy
|
February 26, 2004
Intrapatient variability of efavirenz concentrations as a predictor of virologic response to antiretroviral therapy
Richard C Brundage, Florence H Yong, Terence Fenton, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
May 4, 2026
Quantification of nirmatrelvir concentrations in rat plasma, cerebrospinal fluid, and peripheral blood mononuclear cell extracts using LC-MS/MS
Timothy M Mykris, Lee Winchester, Johid R Malik, et al.
Journal of Clinical Pharmacology
|
January 15, 2011
Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men
Obi C Umeh, Judith S Currier, Jeong-Gun Park, et al.
Antimicrobial Agents and Chemotherapy
|
April 2, 2014
Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women
Caroline Mitchell, Emily Roemer, Evangelyn Nkwopara, et al.
The Journal of Infectious Diseases
|
March 20, 2004
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359
Courtney V Fletcher, Hongyu Jiang, Richard C Brundage, et al.
Scientific Reports
|
July 30, 2020
Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics
Shetty Ravi Dyavar, Timothy M Mykris, Lee C Winchester, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 10, 2008
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients
Jennifer J Kiser, Christina L Aquilante, Peter L Anderson, et al.
Page
of 17